VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials

✍ Scribed by Diether Lambrechts; Bart Claes; Paul Delmar; Joke Reumers; Massimiliano Mazzone; Betül T Yesilyurt; Roland Devlieger; Chris Verslype; Sabine Tejpar; Hans Wildiers; Sanne de Haas; Peter Carmeliet; Stefan J Scherer; Eric Van Cutsem

• Book ID: 117786130
• Publisher: The Lancet
• Year: 2012
• Tongue: English
• Weight: 803 KB
• Volume: 13
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/s1470-2045(12)70231-0